SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
137 hedge funds and large institutions have $1.37B invested in Sage Therapeutics in 2015 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 53 increasing their positions, 41 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
2% more funds holding
Funds holding: 134 → 137 (+3)
25% less call options, than puts
Call options by funds: $5.22M | Put options by funds: $6.95M
Holders
137
Holding in Top 10
6
Calls
$5.22M
Puts
$6.95M
Top Buyers
| 1 | +$48.7M | |
| 2 | +$41.3M | |
| 3 | +$30.2M | |
| 4 |
Jennison Associates
New York
|
+$14.9M |
| 5 |
Bank of New York Mellon
New York
|
+$13.3M |
Top Sellers
| 1 | -$20.4M | |
| 2 | -$17.7M | |
| 3 | -$10.8M | |
| 4 |
AC
Apex Capital
Orinda,
California
|
-$7.29M |
| 5 |
HLA
Hamilton Lane Advisors
Conshohocken,
Pennsylvania
|
-$6.74M |